{"product_id":"ucla-heart-failure-symposium-2024","title":"UCLA Heart Failure Symposium 2024","description":"\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"bundle--hms_paragraph_with_feature paragraph paragraph--type--hms-paragraph-with-feature paragraph--view-mode--default row\"\u003e\n\u003cdiv class=\"columns small-12 medium-8 large-9 medium-order-2\"\u003e\n\u003cdiv class=\"field field--name-field-hms-pwf-paragraphs field--type-entity-reference-revisions field--label-hidden field__items\"\u003e\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"prod-title\"\u003e\n\u003ch3 class=\"product_title entry-title\"\u003eUCLA Heart Failure Symposium 2024\u003c\/h3\u003e\n\u003cstrong\u003eInclude: 16 videos + 14 pdfs, size: 4.99 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Target Audience: family practitioners, internists, cardiologists, pediatricians\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cbr\u003e\u003cbr\u003eHeart failure affects approximately six million Americans and is the most common diagnosis for acute hospitalization in patients over 65 years. Over the next decade, we will see a dramatic increase in the number of patients in the community with advanced heart failure who can benefit from advanced therapies for complex cardiac disease. Academic medical centers, such as UCLA, have an opportunity to integrate treatment advances into a comprehensive patient-centered heart failure management program. UCLA Health wants to enhance the role of the primary care physician and primary cardiologist as the central provider for continuity of care for these complex heart failure patients.\u003cbr\u003e\u003cbr\u003eThe 12th Annual UCLA Heart Failure Symposium 2024 will:\u003cbr\u003e1. Discuss general heart failure treatment options including short and long term mechanical circulatory support therapy, heart transplantation, pulmonary hypertension management, high risk percutaneous and structural interventions, and complex congenital heart disease management.\u003cbr\u003e2. Emphasize the need for developing networks linking academic centers with community physicians to manage these patients through the evolution of their disease pre and post advanced cardiac intervention.\u003cbr\u003e3. Discuss heart failure therapies in cardio-oncology, amyloidosis and new medication updates, as well as address patient and care-provider’s specific needs and perspectives.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\u003cbr\u003eFamily practitioners, internists, cardiologists, pediatricians, nurses and all other healthcare professionals taking care of heart failure patients, as well as the interested lay public.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eLearning Objectives\u003c\/strong\u003e\u003cbr\u003eAt the conclusion of the program participants will be able to:\u003cbr\u003e• Identify the epidemiology and pathophysiology of heart failure and the need for mechanical circulatory support with a growing heart failure population.\u003cbr\u003e• Identify indications for and management of lifelong left ventricular assist device therapy.\u003cbr\u003e• Implement shared care programs with the community and co-manage patients in need of complex cardiac therapies including LVAD therapy, heart transplantation, pulmonary hypertension management, high risk percutaneous interventions, and complex congenital heart disease management.\u003cbr\u003e• Discuss the comprehensive multidisciplinary care and services available to complex cardiac patients within the UCLA Heart Failure Program.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e229741_BROCHURE.pdf\u003cbr\u003eAdvances in Structural Heart Disease Mitral and Tricuspid Percutaneous Interventions.mp4\u003cbr\u003eAdvances in Structural Heart Disease Mitral and Tricuspid Percutaneous Interventions.pdf\u003cbr\u003eAfib Ablation in Heart Failure – King of the Castle.mp4\u003cbr\u003eAfib Ablation in Heart Failure – King of the Castle.pdf\u003cbr\u003eAI, Sensors and Wearable Devices in Heart Failure in 2024.mp4\u003cbr\u003eAI, Sensors and Wearable Devices in Heart Failure in 2024.pdf\u003cbr\u003eCardio-Oncology Immune Check Inhibitor Myocarditis.mp4\u003cbr\u003eCardio-Oncology Immune Check Inhibitor Myocarditis.pdf\u003cbr\u003eCardiogenic Shock- From Mobile ECMO to ECPELLAs.mp4\u003cbr\u003eCardiogenic Shock- From Mobile ECMO to ECPELLAs.pdf\u003cbr\u003eHFPEF- Diagnosis, Treatments, and Patient Impacts.mp4\u003cbr\u003eHFPEF- Diagnosis, Treatments, and Patient Impacts.pdf\u003cbr\u003eIn the Thick of It, Infiltrative Cardiomyopathies.mp4\u003cbr\u003eIn the Thick of It, Infiltrative Cardiomyopathies.pdf\u003cbr\u003eLVADs From the Temporary to the Durable.mp4\u003cbr\u003eLVADs From the Temporary to the Durable.pdf\u003cbr\u003eManage Your Risk Updates in Hyperlipidemia and Hypertension Management in 2024.mp4\u003cbr\u003eManage Your Risk Updates in Hyperlipidemia and Hypertension Management in 2024.pdf\u003cbr\u003ePharmacologic Options for Managing Obesity in Patients with Heart Failure.mp4\u003cbr\u003ePharmacologic Options for Managing Obesity in Patients with Heart Failure.pdf\u003cbr\u003eRobotic Surgical Interventions Minimally Invasive Mitral Surgery.mp4\u003cbr\u003eState of the Art Medical Therapies in Advanced Heart Failure What is New in 2024.mp4\u003cbr\u003eState of the Art Medical Therapies in Advanced Heart Failure What is New in 2024.pdf\u003cbr\u003eState of the Art Updates on Aortic Aneurysms.mp4\u003cbr\u003eState of the Art Updates on Aortic Aneurysms.pdf\u003cbr\u003eToday’s Heart Failure Clinic A Modern Approach.mp4\u003cbr\u003eWhat’s New in Cardio-Obstetrics in 2024.mp4\u003cbr\u003eWhen to Refer- A Tale of Two Patients.mp4\u003cbr\u003eWhen to Refer- A Tale of Two Patients.pdf\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954477109346,"sku":"MED-AMB04136","price":30.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/UCLA-Heart-Failure-Symposium-2024.jpg?v=1779377470","url":"https:\/\/meducourse.com\/products\/ucla-heart-failure-symposium-2024","provider":"Meducourse","version":"1.0","type":"link"}